{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:53:28Z","timestamp":1790708008347,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00192-022-05359-3","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T06:13:31Z","timestamp":1663654411000},"page":"1253-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Peroneal electrical transcutaneous neuromodulation in the home treatment of the refractory overactive bladder"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-5926","authenticated-orcid":false,"given":"Jan","family":"Krhut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Rejchrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Slovak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman V.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Grepl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zvara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"5359_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167\u201378.","journal-title":"Neurourol Urodyn"},{"key":"5359_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"I Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L, Roberts RG, Th\u00fcroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760\u20136.","journal-title":"BJU Int"},{"issue":"6","key":"5359_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306\u201314.","journal-title":"Eur Urol"},{"issue":"1","key":"5359_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12894-020-00697-0","volume":"20","author":"S Funada","year":"2020","unstructured":"Funada S, Watanabe N, Goto T, et al. Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial. BMC Urol. 2020;20(1):129.","journal-title":"BMC Urol"},{"key":"5359_CR5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1080\/14656566.2018.1532502","volume":"19","author":"R Bientinesi","year":"2018","unstructured":"Bientinesi R, Sacco E. Managing urinary incontinence in women\u2014a review of new and emerging pharmacotherapy. Expert Opin Pharmacother. 2018;19:1989\u201397.","journal-title":"Expert Opin Pharmacother"},{"key":"5359_CR6","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1007\/s12325-019-01098-y","volume":"36","author":"M Ali","year":"2019","unstructured":"Ali M, Grogan S, Powell S, et al. Qualitative analysis of factors influencing patient persistence and adherence to prescribed overactive bladder medication in UK primary care. Adv Ther. 2019;36:3110\u201322.","journal-title":"Adv Ther"},{"key":"5359_CR7","first-page":"1","volume":"6","author":"S Tilborghs","year":"2022","unstructured":"Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Rev Med Devices. 2022;6:1\u201327.","journal-title":"Expert Rev Med Devices"},{"key":"5359_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00192-019-04186-3","volume":"31","author":"AA Bhide","year":"2020","unstructured":"Bhide AA, Tailor V, Fernando R, Khullar V, Digesu GA. Posterior tibial nerve stimulation for overactive bladder\u2014techniques and efficacy. Int Urogynecol J. 2020;31:865\u201370.","journal-title":"Int Urogynecol J"},{"key":"5359_CR9","doi-asserted-by":"publisher","first-page":"4016346","DOI":"10.1155\/2021\/4016346","volume":"2021","author":"J Krhut","year":"2021","unstructured":"Krhut J, Peter L, Rejchrt M, Slovak M, Skugarevska B, Zvara P. Peroneal electric transcutaneous neuromodulation (eTNM\u00ae): a novel method for the treatment of the overactive bladder. J Healthc Eng. 2021;2021:4016346.","journal-title":"J Healthc Eng"},{"issue":"7","key":"5359_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1159\/000522570","volume":"106","author":"J Krhut","year":"2022","unstructured":"Krhut J, Rejchrt M, Skugarevska B, Grepl M, Zvara P. Peroneal electrical transcutaneous neuromodulation as a new treatment for patients with overactive bladder: an initial clinical experience. Urol Int. 2022;106(7):658\u201363.","journal-title":"Urol Int"},{"key":"5359_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2490-12-26","volume":"12","author":"SM Notte","year":"2012","unstructured":"Notte SM, Marshall TS, Lee M, et al. Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder. BMC Urol. 2012;12:26.","journal-title":"BMC Urol"},{"key":"5359_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02850085","volume":"22","author":"KS Coyne","year":"2005","unstructured":"Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 2005;22:381\u201394.","journal-title":"Adv Ther"},{"key":"5359_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/nau.23420","volume":"37","author":"AC Peterson","year":"2018","unstructured":"Peterson AC, Sehgal A, Crump RT, Baverstock R, Sutherland JM, Carlson K. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory. Neurourol Urodyn. 2018;37:1095\u2013100.","journal-title":"Neurourol Urodyn"},{"key":"5359_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","volume":"31","author":"M Wang","year":"2020","unstructured":"Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020;31:2457\u201371.","journal-title":"Int Urogynecol J"},{"key":"5359_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00192-018-3822-0","volume":"30","author":"S Iyer","year":"2019","unstructured":"Iyer S, Laus K, Rugino A, et al. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2019;30:1253\u20139.","journal-title":"Int Urogynecol J"},{"key":"5359_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/nau.24254","volume":"39","author":"MJ Te Dorsthorst","year":"2020","unstructured":"Te Dorsthorst MJ, Heesakkers JPFA, van Balken MR. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Neurourol Urodyn. 2020;39:702\u20136.","journal-title":"Neurourol Urodyn"},{"key":"5359_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/nau.23843","volume":"38","author":"I Ram\u00edrez-Garc\u00eda","year":"2019","unstructured":"Ram\u00edrez-Garc\u00eda I, Blanco-Ratto L, Kauffmann S, Carralero-Mart\u00ednez A, S\u00e1nchez E. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: randomized control trial. Neurourol Urodyn. 2019;38:261\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"5359_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/luts.12087","volume":"7","author":"T Yamanishi","year":"2015","unstructured":"Yamanishi T, Kaga K, Fuse M, Shibata C, Uchiyama T. Neuromodulation for the treatment of lower urinary tract symptoms. Low Urin Tract Symptoms. 2015;7(3):121\u201332.","journal-title":"Low Urin Tract Symptoms"},{"key":"5359_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU Guideline Amendment 2019. J Urol. 2019;202:558\u201363.","journal-title":"J Urol"},{"key":"5359_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11934-012-0274-9","volume":"13","author":"DR Staskin","year":"2012","unstructured":"Staskin DR, Peters KM, MacDiarmid S, Shore N, de Groat WC. Percutaneous tibial nerve stimulation: a clinically and cost-effective addition to the overactive bladder algorithm of care. Curr Urol Rep. 2012;13:327\u201334.","journal-title":"Curr Urol Rep"},{"key":"5359_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.urology.2020.04.102","volume":"142","author":"J Jiang","year":"2020","unstructured":"Jiang J, Patil D, Traore EJ, Hammett J, Filson CP. Contemporary patterns of third-line treatments for privately insured individuals with overactive bladder in the United States. Urology. 2020;142:87\u201393.","journal-title":"Urology"},{"issue":"3699","key":"5359_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.150.3699.971","volume":"150","author":"R Melzack","year":"1965","unstructured":"Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971\u20139.","journal-title":"Science"},{"issue":"22","key":"5359_CR23","first-page":"00630","volume":"S1094-7159","author":"AM Sayner","year":"2022","unstructured":"Sayner AM, Rogers F, Tran J, et al. Transcutaneous tibial nerve stimulation in the management of overactive bladder: a scoping review. Neuromodulation. 2022;S1094-7159(22):00630\u20134.","journal-title":"Neuromodulation"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-022-05359-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:42:18Z","timestamp":1685695338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-022-05359-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5359"],"URL":"https:\/\/doi.org\/10.1007\/s00192-022-05359-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"16 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.K. is a consultant for Coloplast, Medtronic, and STIMVIA<sup>\u00ae<\/sup>; M.R. is an investigator for STIMVIA<sup>\u00ae<\/sup>; M.S. and R.V.D. are consultants for STIMVIA<sup>\u00ae<\/sup>; M.G. and P.Z. have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}